Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Moodys

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Pevonedistat


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Pevonedistat?

Pevonedistat is an investigational drug.

There have been 34 clinical trials for Pevonedistat. The most recent clinical trial was a Phase 2 trial, which was initiated on November 28th 2017.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are National Cancer Institute (NCI), Millennium Pharmaceuticals, Inc., and Takeda.

There are one hundred and fifty-six US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Pevonedistat
TitleSponsorPhase
A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic SyndromesTakedaPhase 2
Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid TumorM.D. Anderson Cancer CenterPhase 1/Phase 2
Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and PevonedistatMillennium Pharmaceuticals, Inc.Phase 2

See all Pevonedistat clinical trials

Clinical Trial Summary for Pevonedistat

Top disease conditions for Pevonedistat
Top clinical trial sponsors for Pevonedistat

See all Pevonedistat clinical trials

US Patents for Pevonedistat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pevonedistat ⤷  Try it Free Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines Signal Pharmaceuticals, LLC (San Diego, CA) ⤷  Try it Free
Pevonedistat ⤷  Try it Free Treatment of ophthalmic conditions by selectively removing senescent cells from the eye Unity Biotechnology, Inc. (Brisbane, CA) Buck Institute for Research on Aging (Novato, CA) Mayo Foundation for Medical Education and Research (Rochester, MN) ⤷  Try it Free
Pevonedistat ⤷  Try it Free Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D- ]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamate Millennium Pharmacetuicals, Inc. (Cambridge, MA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.